Results 321 to 330 of about 180,829 (383)

B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab-Mediated B Cell Depletion in Rheumatic Diseases. [PDF]

CPT Pharmacometrics Syst Pharmacol
Nakada T, Mager DE.
europepmc   +1 more source

Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B‐Cell Acute Lymphoblastic Leukaemia

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Histiocytic sarcoma (HS) is a rare neoplasm derived from non‐Langerhans histiocytic cells, exceptionally arising from B‐ALL. Methods We present the case of a child with high‐risk B‐ALL with PAX5 P80R mutation. Results Despite initial remission, a chemoresistant paravertebral mass was identified as HS.
Laetitia Largeaud, Charlotte Syrykh, Julie Vial, Alban Canali, Isabelle Luquet, François Vergez, Stéphanie Dufrechou, Naïs Prade, André Baruchel, Bastien Gerby, Marie Nolla, Eric Delabesse, Marlène Pasquet   +12 more
wiley   +1 more source

Informe preliminar del estudio de desarrollo marcación y estabilidad de un radiofármaco basado en el anticuerpo monoclonal anti-CD20 con I-131, utilizado para la detección temprana de linfomas

, 2006
Roberto Koga, Bertha Ramos, Arturo Portilla, Manuel Otero, Luis Huatay, Luis Gonzáles, Jorge Herrera, Conrado Seminario   +7 more
openalex   +1 more source

Identification of an Elusive CBFA2T3::GLIS2 Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome Sequencing

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Advancements in genomic profiling have significantly improved the classification and treatment strategies for acute myeloid leukemia (AML). However, widely utilized molecular diagnostic techniques, including targeted gene panels, are often insufficient for detecting complex structural variants, cryptic fusions, and poorly characterized driver ...
Yuna Lee, Jung Yoon Choi, Hyun Jin Park, Bo Kyung Kim, Hyun Kyung Kim, Yeseul Kim, Jung‐Eun Cheon, Sung‐Hye Park, Ji Hoon Phi, Ji Won Lee, Ryul Kim, June‐Young Koh, Hyoung Jin Kang   +12 more
wiley   +1 more source

CD56^brightNK cells are negatively associated with antibody response to vaccination in people with multiple sclerosis on B-cell-depleting therapy. [PDF]

Clin Transl Immunology
Perkins GB, Hope CM, Chai CS, Tunbridge MJ, Sterling S, Webb K, Yap J, Yeow AEL, Masavuli MG, Scaffidi J, Zuiani JD, Akerman A, Aggarwal A, Milogiannakis V, Roberts MB, Hurtado PR, Turville S, Grubor-Bauk B, Barry SC, Ravindran J, Coates PT, Hissaria P.   +21 more
europepmc   +1 more source

Investigation of CD8, CD20 and their Correlation with Heat Shock Protein 90 in Breast Cancer Patients

Tuqa Alaa Nuaman, Hayfaa Mahmood Fahad
openalex   +2 more sources

Clinical Profile and Chemotherapy Outcomes of Adult Lymphoma Patients at Jimma University Medical Center: A 2‐Year Retrospective Study

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Lymphoma, including Hodgkin (HL) and non‐Hodgkin (NHL) subtypes, is a leading non‐infectious cause of morbidity and mortality in Ethiopia. Diagnosis relies on histopathology with immunohistochemistry or flow cytometry; staging and prognosis use laboratory tests and imaging.
Kisi Chemeda Gutema, Ramadan Jemal Dekema, Rahmeto Kedir Gudiso, Alemayehu Abebe Guji, Melat Dadigaba Ahmed, Desalegn Gizaw Fikremaram, Merid Lemma Kebede, Selam Tesfaye Genet, Kedir Negesso Tukeni   +8 more
wiley   +1 more source

Switching high efficacy therapies in Multiple Sclerosis: Does real world experience support such a strategy? [PDF]

Neurotherapeutics
Dhib-Jalbut S.
europepmc   +1 more source

Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders

MedComm, Volume 7, Issue 4, April 2026.
CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley   +1 more source